Estimated glomerular filtration rate is a marker of mortality in the European Scleroderma Trials and Research Group (EUSTAR) database

Gigante A, Hoffmann-Vold AM, Fegatelli DA, Gabrielli A, Leodori G, Coleiro B, De Santis M, Dagna L, Alegre-Sancho JJ, Montecucco C, Carreira PE, Balbir-Gurman A, Doria A, Riemekasten G, Airo P, Distler J, Distler O, Rosato E (2022)


Publication Type: Journal article

Publication year: 2022

Journal

Book Volume: 61

Pages Range: 213-222

Journal Issue: 1

DOI: 10.1093/rheumatology/keab302

Abstract

Objectives. The study aim was to evaluate the estimated glomerular filtration rate (eGFR), its association with clinical disease and its predictive ability with respect to mortality in SSc patients from the European Scleroderma Trials and Research Group (EUSTAR) database.

Authors with CRIS profile

Involved external institutions

How to cite

APA:

Gigante, A., Hoffmann-Vold, A.-M., Fegatelli, D.A., Gabrielli, A., Leodori, G., Coleiro, B.,... Rosato, E. (2022). Estimated glomerular filtration rate is a marker of mortality in the European Scleroderma Trials and Research Group (EUSTAR) database. Rheumatology, 61(1), 213-222. https://doi.org/10.1093/rheumatology/keab302

MLA:

Gigante, Antonietta, et al. "Estimated glomerular filtration rate is a marker of mortality in the European Scleroderma Trials and Research Group (EUSTAR) database." Rheumatology 61.1 (2022): 213-222.

BibTeX: Download